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ARTICLE
Mitochondrial DNA–Deletion Mutations Accumulate
Intracellularly to Detrimental Levels in Aged Human Skeletal
Muscle Fibers
Entela Bua, Jody Johnson, Allen Herbst, Bridget Delong, Debbie McKenzie, Shahriar Salamat,
and Judd M. Aiken
Skeletal muscle–mass loss with age has severe health consequences, yet the molecular basis of the loss remains obscure.
Although mitochondrial DNA (mtDNA)–deletion mutations have been shown to accumulate with age, for these aberrant
genomes to be physiologically relevant, they must accumulate to high levels intracellularly and be present in a signiﬁcant
number of cells. We examined mtDNA-deletion mutations in vastus lateralis (VL) muscle of human subjects aged 49–
93 years, using both histologic and polymerase-chain-reaction (PCR) analyses, to determine the physiological andgenomic
integrity of mitochondria in aging human muscle. The number of VL muscle ﬁbers exhibiting mitochondrial electron-
transport-system (ETS) abnormalities increased from an estimated 6% at age 49 years to 31% at age 92 years. We analyzed
the mitochondrial genotype of 48 single ETS-abnormal, cytochrome c oxidase–negative/succinate dehydrogenase–hy-
perreactive (COX5/SDH++) ﬁbers from normal aging human subjects and identiﬁed mtDNA-deletion mutations in all
abnormal ﬁbers. Deletion mutations were clonal within a ﬁber and concomitant to the COX5/SDH++ region. Quantitative
PCR analysis of wild-type and deletion-containing mtDNA genomes within ETS-abnormal regions of single ﬁbers dem-
onstrated that these deletion mutations accumulate to detrimental levels (190% of the total mtDNA).
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Aging is a complex biological process characterized by a
gradual but constant decline in biochemical and physio-
logical function of many organs. Normal aging is most
evident in, and has the greatest impact on, nonreplicative
tissues (i.e., heart, brain, and skeletal muscle) that rely
heavily onoxidativemetabolism for energy. In skeletalmus-
cle, aging is associated with an inevitable reduction in
musclemass and strength. The process bywhich leanmus-
cle, one of the most metabolically active tissues in the
human body, gradually declines with age is termed “sar-
copenia.”1 Sarcopenia generally begins in the early 40s but
can occur as early as age 25 years.2 By ages 50–60 years,
typically 10%–20% of the muscle mass is lost, and, by age
80 years, the loss increases to 40%.3 In humans and rats,
the age-related loss of muscle mass results from a decrease
in ﬁber number and/or an increase in ﬁber atrophy.2,4–7
In rats, the extent of sarcopenia is muscle speciﬁc, with
some muscles exhibiting signiﬁcant decline in weight and
ﬁber number with age, whereas others appear resistant to
sarcopenia.4,6,8–11
The role of mitochondrial abnormalities in the etiology
of skeletal muscle–ﬁber loss with age has been extensively
characterized in rats and rhesus monkeys.4,10,12 Intraﬁ-
ber atrophy and ﬁber breakage, concomitant with elec-
tron-transport-system (ETS) abnormalities, occur along
the length of muscle ﬁbers.4,10,12 These prototypic ETS en-
zymatic abnormalities, also observed in mitochondrial
myopathies, include a decline in the activity of the par-
tially mitochondrial-encoded complex IV (cytochrome c
oxidase [COX]) and an increase in the nuclear-encoded
complex II activity (succinate dehydrogenase [SDH]). Fi-
bers with longer ETS-abnormal regions are more suscep-
tible to atrophy and breakage.4,12 Muscles that exhibit the
most muscle-mass loss with age—vastus lateralis (VL) and
rectus femoris—also exhibit the largest reduction in ﬁber
number and the greatest number of ETS-abnormal ﬁbers
with associated atrophy.4,10
Age-dependent mtDNA-deletion mutations accumulate
in a number of mammalian tissues. In humans, these mu-
tations appear in the 3rd decade of life and accumulatewith
age in postmitotic tissues, such as skeletal muscle, heart,
and brain.13–15 A 4,977-nt deletion in mtDNA (mtDNA4977)
is the most studied age-associated mtDNA alteration. The
mtDNA4977 deletion, located in the major arc of mtDNA,
is ﬂanked by a 13-bp direct repeat. This mtDNA-deletion
mutation accumulates with age and has been detected in
multiple tissues and numerous individuals.13,16–18 Many
other age-dependent mtDNA deletions of various sizes
have been identiﬁed in analyses of human-tissue homog-
enates. Although these studies have established an age-
associated increase in the number of mtDNA deletions,
the physiological relevance of these mutations has been
questioned, since the abundance of any single mtDNA-
deletion product is low (!1%) when calculated from ho-
mogenate tissue.13,17,19 Given the mosaic and segmental
distribution of deletion mutations and concomitant ETS
470 The American Journal of Human Genetics Volume 79 September 2006 www.ajhg.org
Table 1. Age Distribution, BMI Values, and Medical History of Study Subjects
Subject Sex
Age at
Death
(years) BMIa Medical History and Autopsy Finding(s)
1 Fb,c 49 40.3 Cardiovascular disease, lung disease, and hyperthyroidism
2 Fb,c,d 49 39.1 Cardiovascular disease and kidney failure
3 Fd 58 60.6 Lung disease
4 Fc 60 21.7 Thyroid adenoma and brain tumor
5 Mc,d 64 35.4 Cardiovascular disease and pulmonary edema
6 Mb 67 27.6 Diabetes, nephropathy, and cardiovascular disease
7 Mb,c 76 23.1 Cardiovascular disease and nephropathy
8 Mc,d 79 21.9 Cardiovascular disease and lung disease
9 Fb,c,d 83 32.0 Cardiovascular disease
10 Mb 92 NA Cardiovascular disease, lung disease, and dementia
11 Fb,c,d 92 18.7 Cardiovascular disease and leukemia
12 Fc,d 93 22.0 Cardiovascular disease and nephropathy
a BMI p weight (in kg)/height2 (in cm); 18.5 p underweight; 18.5–24.99 p normal weight;
25–29.99 p overweight; 30.0 p obese. NA p data not available.
b Tissue was used for individual ETS-abnormal ﬁber analysis.
c Tissue was used for mtDNA4977 homogenate analysis.
d Tissue was used for mtDNA7664 homogenate analysis.
abnormalities in muscle ﬁbers,4,20,21 analysis of homoge-
nates is not appropriate for quantitative measurement of
these mutations in single cells. The analysis of deﬁned
numbers of muscle ﬁbers as well as in situ hybridization
studies demonstrate that mtDNA-deletion mutations fo-
cally accumulate to detectable levels in single cells and are
associated with abnormal ETS enzymatic activities.12,20,22,23
Previous histologic studies of human skeletal-musclemi-
tochondrial abnormalities examined single or undeﬁned
numbers of serial tissue sections that demonstrated an ac-
cumulation with age but provided limited information
regarding the abundance of these segmental abnormali-
ties.24–26 In rats and rhesus monkeys, ETS abnormalities are
focal, mosaically distributed among cells, and segmental;
they do not extend throughout the length of the affected
muscle ﬁber but rather are localized to a small region or
segment of the ﬁber.4,10,12,27 Thus, determination of the
total number of ﬁbers containing ETS abnormalities in a
biopsy sample requires extensive histologic analyses of
muscle ﬁbers along their length. Such analysis, in addition
to deﬁning the ETS abnormalities, will also determine the
length of abnormal regions and the cross-sectional area
(CSA) of the ﬁbers.
Formitochondrial enzymatic andmtDNAabnormalities
to contribute to aging processes, a number of criteriamust
be met: (1) mtDNA abnormalities must accumulate intra-
cellularly to high levels, (2) they must cause a phenotype
(ETS abnormality) that, ultimately, has a deleterious cel-
lular effect, and (3) there must be a sufﬁcient number of
cellular abnormalities (ETS-abnormal ﬁbers) to affect tis-
sue function. The analysis of the age-dependent distribu-
tion of mtDNA-deletion mutations in skeletal muscle ne-
cessitates two levels of analysis: quantiﬁcation of mtDNA
deletion–mutation load within ETS-abnormal regions of
single skeletal-muscle ﬁbers and determination of the num-
ber of ﬁbers harboring mtDNA deletions that result in an
abnormal phenotype. We examined the abundance of ETS
abnormalities in aged human skeletal muscle and quanti-
ﬁed the intracellular abundance ofmtDNA-deletionmuta-
tions in ETS-abnormal ﬁbers from humans of diverse ages.
The number of ETS-abnormal ﬁbers (COX/SDH) in-
creased with age. mtDNA-deletion mutations were iden-
tiﬁed in all examined ETS-abnormal ﬁbers and accumu-
lated to 190% of the total mtDNA within ETS-abnormal
regions of single ﬁbers.
Material and Methods
Tissue Collection and Preparation
VL muscle biopsies were collected from 12 human subjects (aged
49–93 years) (table 1) with no known mitochondrialmyopathies.
The biopsies (∼1 g of tissue) were collected within 5 h postmor-
tem, during the course of normal autopsy, at the University of
Wisconsin Hospital and Clinics. Mitochondrial enzymes in mus-
cle tissue retain activity for at least 5 h postmortem and for at
least 10 years when frozen. The tissue was transversely cut into
small pieces, was placed in optimal cutting temperature mount-
ing media (Miles), was ﬂash frozen in liquid nitrogen, and was
stored at 80C. Before cryosectioning, samples were brought to
20C. Two hundred serial sections, 10 mm thick, were cut using
a cryostat and were placed on labeled ProbeOn Plus microscope
slides (Fisher Scientiﬁc).
Histochemical staining for COX and SDH enzyme activitieswas
performed on serial sections, to identify ﬁbers containing ETS-
abnormal regions.28,29 Enzyme incubation media were prepared
as described by Lee et al.30 The ﬁrst slide was stained for COX
activity, the second slide was stained for SDH activity, and the
third slide was sequentially dual-stained for both COX and SDH
activity. Slides 4–7 were used for themtDNA-deletion study. Slides
8, 9, and 10 were stained again for enzyme activities (COX, SDH,
and dual-stained, respectively). This staining patternwas repeated
for 200 slides from each sample. After staining, slides were rinsed
in distilled water and were mounted with aqueous media (Aqua
Poly/Mount [Polysciences]).
Microscopy was performed on an Olympus BH2 microscope
equipped with Hitachi 3-chip CCD camera (Hitachi) under bright
ﬁeld illumination. ImagePro Plus software (Media Cybernetics)
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Table 2. Primers Used to Identify mtDNA Mutations and Primers Used in Quantitative PCR
A. Primers used to identify mtDNA deletion mutations
Primersa
Primer Sequence
(5′r3′) Nucleotide Location
F588 TTACCTCCTCAAAGCAATACACTG 588–602
R2737 AGCTCCATAGGGTCTTCTCGTCTT 2737–2713
F696 TGCAAGCATCCCCGTTCC 696–714
F1775 AGATATAGTACCGCAAGGGAAAGA 1775–1799
R16550 AGGGGAACGTGTGGGCTATTTAGGC 16550–16525
R16424 ATATTGATTTCACGGAGGATGGTG 16424–16400
F8111 CCGGACGTCTAAACCAAACCACTT 8111–8135
R13765 GGGGATGCGGGGGAAATGT 13765–13746
B. Primers used in quantitative PCR to measure the amount of mtDNA-deletion mutations and wild-type mtDNA
Primersa
Primer Sequence
(5′r3′) Nucleotide Location Deletion
F7349 GTCCTAATAGTAGAAGAACCCTCC 7349–7373 4989
R12465 AGGTGGATGCGACAATGG 12465–12448
F6256 GGAGGCCGGAGCAGGAAC 6256–6274 7664
R14144 AGGATTGGGATGAGGATTAGTGT 14144–14122
F8369 CCCAACTAAATACTACCGTATGGC 8369–8394 4977
R13523 CAAAGATGAGGTTTCTGGTGTAGTAG 134523–13498
F12354 ATAACCACCCTAACCCTGACTTCC 12354–12378 Wild type
R12573 GTTTGTTGGGTCGAGAGGGATTCGA 12573–12549
NOTE.—The numbering system for each primer is based on human mitochondrial genome sequences (1–16,569 bp)
(GenBank accession number 1944628).
a F p forward primer; R p reverse primer.
was used to generate composite images of tissue sections by dig-
itally overlapping images captured at 4#magniﬁcation. Eachmus-
cle ﬁber in the sectionwas digitallymarked usingAdobePhotoshop
(Adobe Systems), and ﬁbers displaying ETS enzymatic abnormali-
ties (COX/SDH) were identiﬁed. The total ﬁber count was de-
termined using ImagePro Plus software.
Laser Capture Microdissection
The PixCell II laser capture microdissection (LCM) system (Arc-
turus Bioscience) was used, as described by Cao et al.21 and Gokey
et al.,31 to isolate 10-mm thick ETS-abnormal and ETS-normal
regions of single ﬁbers. Before microdissection, the tissue sections
were subjected to an ethanol and xylene dehydration series for
10–15 min at each step. Any additional noncaptured material
was carefully removed using the Cap-Sure pad (Arcturus Engi-
neering). LCM settings included a laser-spot size of 15 mm, a pulse
power of 60 mW, and a pulse width of 50 ms.
DNA Isolation and Ampliﬁcation
Total DNA was extracted from individual laser-captured skeletal
muscle–ﬁber sections with use of the protocol described byKhrap-
ko et al.32 In brief, 1 ml of digestion solution containing 2 mg/ml
proteinase K, 0.5% sodium dodecyl sulfate, and 10mM EDTAwas
added to each section of skeletal-muscle ﬁber and was incubated
at 37C for 30 min in a humidiﬁed chamber. Subsequently, 10
mml of double-distilled H2O (ddH2O) was added to the original 1
mml of digestion solution. Of the DNA solution from individual
ﬁbers, 1 ml was used for the PCR. Primers used for PCR mtDNA
analyses are summarized in table 2A. Short-extension PCR (94C
for 5 min for “hot start” and 35 cycles at 94C for 30 s, 60C for
30 s, and 72C for 2.5 min) (primers F588–R2737) with Taq DNA
polymerase (Promega) was employed to amplify small mtDNA
fragments, to conﬁrm the presence of mtDNA in the sample. The
Expand Long Template PCR System (Roche) was used to amplify
the whole mtDNA genome (94C for 5 min for hot start, and 35
cycles at 94C for 30 s, 62C for 30 s, and 68C for 16min) (primers
F696 and R16550). Nested PCR was used when necessary (94C
for 5 min for hot start, and 35 cycles at 94C for 30 s, 60C for
30 s, and 70C for 5 min) (primers F1775 and R16424). When an
ampliﬁcation product was obtained, subsequent PCRs were per-
formed using primers internal to the initial set, to deﬁne the
region containing the deletion breakpoints. The ampliﬁcation
products were then gel-puriﬁed and directly sequenced using Big-
Dye terminator cycle sequencing on an ABI 3700 capillary-based
DNA analyzer (Applied Biosystems International) at the Univer-
sity of Wisconsin–Madison DNA Sequencing Facility.
Quantitative PCR Analysis
Quantitative PCR (i.e., real-time PCR) was performed to deter-
mine the abundance of full-length and truncated mtDNA in in-
dividual sections of COX/SDH abnormal ﬁbers. Quantitative
PCR was performed in an iCycler iQ Real Time Detection System
instrument with 12.5 ml of iQ SYBR Green Supermix (Bio-Rad
Laboratories), 0.5 ml of of each primer (10 mM), 0.5 ml of the DNA
solution from individual ﬁbers, and ddH2O to a ﬁnal volume of
25 ml. Primers used for quantitative PCR are listed in table 2B.
The primer sequences for a speciﬁc deletion-containing genome
were based on the unique sequence of each mtDNA-deletionmu-
tation determined from the breakpoint analysis. Deletion-speciﬁc
primer sets ﬂank the breakpoints such that ampliﬁcation of the
deletion-containing genomes yields an ampliﬁcation product of
∼200 bp. The short extension time (∼20 s) in the elongationphase
of the PCR emphasizes the speciﬁc ampliﬁcation of deletion-con-
taining genomes. The wild-type primer set was designed to am-
plify a region of the mtDNA within the deleted portion of the
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Figure 1. Detection of mtDNA-deletion mutations by major arc
mtDNA-genome ampliﬁcation. Total DNA from microdissected COX/
SDH ﬁbers was subjected to long-extension PCR. mtDNA-speciﬁc
primers (F4840–R766) that amplify ∼13 kb of the full-length ge-
nome, including two origins of replication, were used. Full-length
ampliﬁcation products were detected in ETS-normal ﬁbers (n).
Smaller ampliﬁcation products were identiﬁed in ETS-abnormal ﬁ-
bers (8, 11, 28, 31, and 34). Ampliﬁcation of total mtDNA from
tissue homogenates (T) detected both full-length and smaller am-
pliﬁcation products. M p DNA molecular-weight standards.
genome, to ensure that the wild-type primers amplify only full-
length genomes and exclude deletion-containing genomes. The
mtDNA from the laser-captured ﬁbers was ampliﬁed in parallel
with cloned standards that were generated using pGEM T-easy
plasmid (Promega). Concentrations of the standards were deter-
mined by spectrophotometry at A260, and quantitative PCR with
regression analysis was used to determine the accuracy of dilu-
tions. A standard curve was generated for each primer set, and
the starting quantities of full-length and deletion-containingmi-
tochondrial genomes were calculated. Melting-curve analysis and
gel electrophoresis were used to conﬁrm the speciﬁcity of the
ampliﬁcation reactions and the absence of nonspeciﬁc products.
Statistical Analysis
SigmaStat 2.0 (SPSS) was used for statistical analysis. One-way
analysis of variance (ANOVA) was used to determine signiﬁcance
between deletion sizes on the basis of the age groups. Differences
were considered signiﬁcant at .P ! .05
Results
Extent of ETS Abnormalities and Structural Atrophy
in Skeletal-Muscle Fibers of Aging Humans
VL muscle sections from six individuals (subjects 2, 6, 7,
9, 10, and 11) (table 1), with an age range of 49–92 years,
were sectioned and stained for COX activity and SDH ac-
tivity and were sequentially dual-stained for COX and
SDH activities. ETS-abnormal ﬁbers were identiﬁed in all
analyzed human VL biopsies. Determination of abundance
of COX/SDH abnormalities requires extensive analyses
along the length of an affected muscle ﬁber. Two hundred
consecutive sections of tissue were analyzed from muscle
biopsies for three representative ages (49, 67, and 92 years;
subjects 2, 6, and 11, respectively) (table 1). The total ﬁber
number present in each biopsy was determined, and the
percentage of the COX/SDH ﬁbers within the 2,000 mm
of tissue was calculated. These ETS abnormalities exhibited
a mosaic and segmental distribution along the length of
the ﬁbers in the biopsy. Of the 18,367 ﬁbers in the 49-
year-old subject, 36 (0.2%) exhibited an ETS-abnormal
phenotype within the 2,000 mm examined. An ETS-ab-
normal phenotype was exhibited in 65 (0.7%) of the 9,285
ﬁbers in the 67-year-old individual and in 98 (0.92%) of
the 10,652 ﬁbers in the 92-year-old individual. The length
of ETS-abnormal regions had a range of 170–800 mm in
the 49-year-old individual, of 100–800 mm in 67-year-old
individual, and of 660 to 12,000 mm in the 92-year-old
individual.
To determine whether ETS-abnormal ﬁbers exhibit in-
traﬁber atrophy, as is the case with rat and rhesusmonkey,
the CSA of both COX/SDH and ETS-normal ﬁbers was
measured throughout the 2,000 mm of sectioned tissue.
The CSA ratio provides an estimate of the severity of in-
traﬁber atrophy and was calculated by dividing the min-
imumCSA value in the COX/SDH region by the average
CSA value of the normal regionwithin the sameﬁber. Fibers
with ETS-abnormal regions that were contained within the
2,000 mmof sectionedmuscle were analyzed (24 abnormal
ﬁbers from the 49-year-old subject, 20 abnormal ﬁbers
from the 67-year-old subject, and 18 ﬁbers from the 92-
year-old subject). Intraﬁber atrophy (CSA ratio !0.5) was
not observed in any of the analyzed ETS-abnormal ﬁbers
from the 49-year-old subject. Of the ETS-abnormal ﬁbers
from the 67-year-old and 92-year-old individuals, 5% ex-
hibited intraﬁber atrophy.
mtDNA-Deletion Mutations Colocalize with ETS-Abnormal
Regions
LCM was used to isolate 10-mm thick sections of single VL
ﬁbers from both ETS-normal and ETS-abnormal regions.
Forty-eight ﬁbers exhibiting the COX/SDH phenotype
and 20 randomly selected ETS-normal ﬁbers were cap-
tured. Deletion mutations were not identiﬁed in sections
obtained from ETS-normal ﬁbers. PCR analysis identiﬁed
mtDNA-deletion mutations in all ETS-abnormal regions
of the examined ﬁbers (ﬁg. 1 and table 3). Every ETS-ab-
normal ﬁber ampliﬁed a single, smaller-than-wild-type
product by long-extension PCR. The size of the deletion
generally differed from ﬁber to ﬁber and varied from 154
bp to 12,808 bp, which resulted in truncated mtDNA ge-
nomes of 16,415 bp to 3,761 bp (table 3). No signiﬁcant
difference ( ) was observed in the size of the deletionP 1 .05
between individuals of different ages (49–92 years).
mtDNA-Deletion Mutations Present
throughout the Mitochondrial Genome
Direct mtDNA sequencing determined the breakpoints of
each identiﬁed deletion mutation. The majority (96%) of
the mutations were the result of deletions within the ma-
www.ajhg.org The American Journal of Human Genetics Volume 79 September 2006 473
Table 3. Nucleotide-Breakpoint Location
and Deletion Size
Subjecta
(Age [in years], Sex)
and Fiber Number
Nucleotide
Breakpoint
Deletion
Size
(bp)
1 (49, F):
1 7478–5–11439 3,961
2 11513–––13809 2,296
3 11738–––15571 3,833
4 6862–––13060 6,198
5 5786–––13923 8,137
6 6340–16–14004 7,664
7 5786–––15575 9,789
2 (49, F):
8 9799–––15556 5,757
9 9920–––16070 6,149
10 6427–––14100 7,672
11 9665–––15182 5,517
12 8562–7–13953 5,385
6 (67, M):
13 7181–4–14560 7,383
14 9237–4–13053 3,812
15 7722–––14109 6,387
16 7164–10–14109 6,935
17 9758–7–13748 3,983
7 (76, M):
18 4880–––16066 11,185
19 6340–16–14004 7,664
20 10928–5–15524 4,591
21 7398–––13676 6,276
22 9342–8–13145 3,803
23 7395–11–12384 4,989
24 9577–9–13952 4,366
9 (83, F):
25 9243–7–14421 5,171
26 8466–9–14362 5,905
27 12083–4–15853 3,772
28 7413–13–14570 7,170
29 16157–7–16318 154
30 6340–16–14004 7,664
31 7849–––13473 5,624
32 8554–6–13984 5,424
10 (92, M):
33 6939–7–15450 8,311
34 6521–9–15049 8,728
35 10492–4–14751 4,263
36 6340–16–14004 7,664
37 6329–16–13993 7,664
38 6939–4–15450 8,511
39 6939–4–15450 8,511
40 3262–––16070 12,808
11 (92, F):
41 10969–7–15535 4,559
42 7856–––12282 4,426
43 11046–9–15850 4,795
44 10969–7–15535 4,559
45 10931–4–15541 4,606
46 5788–––16074 10,286
47 5785–––16071 10,288
48 7097–––16071 8,974
NOTE.—The numbering system is based on human mitochon-
drial genome sequences (1–16569 bp) (GenBank accession num-
ber 1944628). The left and right breakpoints are separated by
dashes (–––); numbers between the dashes indicate the size of
direct repeat sequences in the base pair.
a See table 1.
jor arc of mtDNA, with both origins of replication pre-
served. Deletion mutations present in two ﬁbers resulted
in the removal of a portion of the minor arc and the light
strand origin of replication (OL) (table 4). All mutations
resulted in the partial or entire removal of the mitochon-
drial-protein functional genes (table 4). mtDNA deletions
were clonal within an ETS-abnormal region; that is, when
the same ﬁber was sampled from different sections within
the COX/SDH region, the same deletion mutation, de-
ﬁned by mtDNA sequence analysis, was observed. Most de-
letionmutations were unique to a given ﬁber. OnemtDNA
deletion mutation, with 7,664 bp (mtDNA7664) removed,
was identiﬁed in the ETS-abnormal region of ﬁve ﬁbers.
Another deletion mutation, mtDNA4559, was observed in
two different ETS-abnormal ﬁbers from a 92-year-old in-
dividual. A third common deletion mutation, mtDNA8511,
was observed in two ﬁbers (tables 3 and 4).
The deletion breakpoints occurred throughout the ge-
nome, with the highest concentration observed in the
ND5 (∼41%) (GenBank accession number 2052366), Cytb
(∼33%) (GenBank accession number AAB58955), COXI
(∼33%) (GenBank accession number AAB58945), and
COXIII (∼16%) (GenBank accession number 2052365)
genes (ﬁg. 2). The majority of the mutations contained
direct repeat sequences at the breakpoints. The size of di-
rect-repeat sequences typically had a range of 4–16 bp in
length, with one repeat deleted and the othermaintained.
In two ﬁbers, the direct repeats were partially deleted (ta-
ble 4). Of the repeats, ∼65% were perfect (identical se-
quences ﬂanking the deletion breakpoints), whereas im-
perfect direct repeats (repeats differing in sequence by 1
or 2 nt) were present in other deletions (table 4).
mtDNA-Deletion Mutations Accrue to High Levels
in the ETS-Abnormal Region of Human Skeletal-Muscle
Fibers
The mtDNA-deletion load present in 10-mm thick sections
from single LCM-dissected ﬁbers was measured by quan-
titative PCR. The absolute level of deletion-containingand
full-length mitochondrial genomes was determined along
the length of four muscle ﬁbers exhibiting the COX/
SDH phenotype. Three of the ﬁbers (19, 36, and 37)
contained the deletion mutation mtDNA7664, removing
nucleotides 6340–14004, and one ﬁber (23) contained the
deletion mutation mtDNA4989, removing nucleotides 7395–
12384 of the mitochondrial genome. Total mtDNA in-
creased in the COX/SDH region, an increase resulting
from the accumulation of the speciﬁc mtDNA-deletion
mutation. The amount of full-lengthDNAdid not increase
in the ETS-abnormal region. Full-length genomes were de-
tected in both ETS-normal and -abnormal regions, with
the abundance typically declining in the COX/SDH
regions (see ﬁg. 3).
The mtDNA deletion–mutation load approached 99%
of the mtDNA within each ﬁber’s COX/SDH abnormal
region (ﬁg. 4). An intermediate ETS phenotype (COXlow/
SDHhigh) was observed in sections adjacent to the COX/
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Table 4. Breakpoints of Deletion Mutations
Fiber Breakpoint Sequence
Deleted
Genes
1 AGGAAGGAACCCCCCAAA(GCTGG)—(GCTGG)GTCAATAGTACTTGCCGCAG tRNAser—ND4
2 TATAATACGCCTCACACTCATTCTCAACCC—GCTGTCACTTTCCTAGGACTTCTAACAG ND4—ND5
3 CGCCCACGGGCTTACATCCTCATTACTATT—TTCGCCTACACAATTCTCCGATCCGTCC ND4—Cytb
4 ATCATCGCTATCCCCACCGGCGTCAAAGT—CAGTCTCAGCCCTACTCCACTCAAGCA COXI—ND5
5 GAGAAGCCCCGGCAGGTTTGAAGCTGCTTC—CCTAGCATCACACACCGCACAATCCCC tRNAcys—ND5
6 CCTGGAG(CCTCCGTAGACCTAACC)—(cctcctagacctaacc) TGACTAGAA COXI—ND5
7 GCCCCGGCAGGTTTGAAGCTGCTTC—CCTACACAATTCTCCGATCCGTCCCTAAC tRNAcys—Cytb
8 TTTCCGACGGCATCTACGGCTCAACATTTTT—GAATGATATTTCCTATTCGCCTACACAA COXIII—Cytb
9 CCAAACATCACTTTGGCTTCGAAGCCGCCG—CCCATCAACAACCGCTATGTATTTCGTA COXIII—HVS1
10 ATCAATATAAAACCCCCTGCCA—CTCTCTTTCTTCTTCCCACTCATCCTA COXI—ND5
11 ACCTGAGCTCACCATAGTCTAATAGAA—TTACAAACTTACTATCCGCCATCCCATAC COXIII—Cytb
12 ATTCATTGCCCCCACAATC(CTAGGCCT)—(CTAGGCCT)TCTTACGAGCCAAAACCTG ATP6—ND5
13 CATCGGCGT AAATCTAACTTTCTTC(CACC)—(CACC)GCTAACAATCAATACTAAACCC COXI—ND6
14 CCTATCATATAGTAAAA(CCCA)—(CCCA)CCCCAGTCTCAGC COXIII—ND5
15 ATGCCCTTTTCCTAACACTC—TCTTCTTCCCACTCATCCTA COXII—ND5
16 TAAATCTAACT(TTCTTCCCAC)—(TTCTTCCCAC)TCATCCTAACCCTA COXI—ND5
17 AGTCTCCCTTCAC(CATTTCC)—(CATTTCC)CCCGCATCCCCCTTC COXIII—ND5
18 TTCTTCTCACATGACAAAAACTAGCCC—CTCACCCATCAACAACCGCTATGTATT ND2—HVS1
19 CCTGGAG(CCTCCGTAGACCTAACC)—(cctcctagacctaacc) TGACTA COXI—ND5
20 CCCCAACCTTTTCCTCCG(ACCCC)—(ACCCC)TTAAACACCCCTCCCCAAT ND4—Cytb
21 AGTGACTATATGGATGCCCCCC—CCCCACCCTACTAAACCCCATTCG COXI—ND5
22 ACGCTCCTCATACTAGG(cctactaa)—(CCCACTAA)TCCAAACTCTAAC COXIII—ND5
23 CTATATGGATG(CCCCCCACCCT)—(ccccccatcct)TACCACCCCGTT COXI—ND5
24 GGCATCACCCCGCTA(AATCCCCTA)—(AATCCCCTA)TCTAGGCCTTCTT COXIII—ND5
25 ATATAGTAAAACCCAGCCCA(TGACCCC)—(TGACCCC)CATGCCTCAGGATACTCCT COXIII—ND6
26 ATATTAAACACAAACTACCA(CCTACCTCC)—(CCTACCTCC)ATCGCTAACCCCACTAAA ATP6—ND6
27 GAAAACACCCTCATGTTCATACAC(CTATC)—(CTATC)TCCCTAATTGAAAACAAAATACT ND4—Cytb
28 TATGGATGCCCCC(CACCCTACCACAC)—(cacccgaccacac) CGCTAACAATCAAT COXI—ND6
29 TAAATACTTGACCACCTGTAGT(ACATAAA)—(ACATAAA)GCCATTTACCGTACATAGCA HVS1—HVS1
30 TGGAGCCTCCG(TAGACCTAACC)—(cctccTAGACCTAACC) TGACTAGAAAA COXI—ND5
31 CTACGCATCCTTTACATAACAGACG—TTAGCAGGAATACCTTTCCTCACAGG COXII—ND5
32 AATCTGTTCGCTTCATTCAT(TGCCCC)—(TGCCCC)ACTCCTCCTAGACCTAACCT ATP6—ND5
33 CAGTGCTCTGAGCCCTAGGA(TTCATCTT)—(ttctctt)CCTTCTCTCCTTAA COXI—Cytb
34 AGTCCTAGCTGCTGGCATCA(ctatactac)—(CTATATTAC)GGATCATTTCTCTACTCA COXI—Cytb
35 CCCTCATTTACATAAATATT(ATAC)—(ATAC)GCAAAACTAACCCCCTAATAA ND4—Cytb
36 CCTGGAG(CCTCCGTAGACCTAACC)—(cctcctagacctaacc) TGACTAGAA COXI—ND5
37 CCTGGAG(CCTCCGtagacctaacc)—(cctccTAGACCTAACC)TGACTAGA COXI—ND5
38 GCAGTGCTCTGAGCCCTAGGATTCA(TCTT)—(TCTT)CCTTCTCTCCTTAATGACATTAACA COXI—Cytb
39 GCAGTGCTCTGAGCCCTAGGATTCA(TCTT)—(TCTT)CCTTCTCTCCTTAATGACATTAACA COXI—Cytb
40 TAATACTAACTACCTGACTCCT(ACCCCTC)—(ACCCCTC)CCCACATCAAGCCCGAATG tRNAleu—Cytb
41 CGCATCCTTTACATAACAGACGAGGTCAA—GCTATCCATTGGTCTTAGGCCCCAAAA ND4—Cytb
42 ACTCTACCTCTCTATACTA (ATCTCCCTA)—(ATCTCCCTA)ATTGAAAACAAAAT COXII—ND4
43 TAATACTAACTACCTGACTCCT(ACCCCTC)—(ACCCCTC)CCCACATCAAGCCCGAATG ND4—Cytb
44 CTGTTCCCCAACCTTTTCCTCCGAC(CCCC)—(CCCC)ACATCAAGCCCGAATGATATTTC ND4—Cytb
45 AGCGGCAGGTTTGAAGCTGCTTCTT—TCAACAACCGCTATGTATTTCGTACAT ND4—Cytb
46 AGCCCCGGCAGGTTTGAAGCTGCT—CCATCAACAACCGCTATGTATTTCGAT OL—HVS1
47 ATAGGAGGCTTCATTCACTGATTTCCCC—CCATCAACAACCGCTATGTATTTCGTA OL—HVS1
48 GATGGCAGAGCCCGGTAATCGCATAAAAC—CCCATCAACAACCGCTATGTATTTCGTAC COXI—HVS1
NOTE.—The breakpoint sequence is based on human mitochondrial genome sequences (1–16,569
bp) (GenBank accession number 1944628). Letters in parentheses represent direct repeats ﬂanking
the breakpoints. Imperfect direct repeats are shown in bold italics. Deleted nucleotides are in lower-
case letters.
SDH regions. Deletion mutations were present in these
transition regions, albeit at a lower abundance (30%–
40%) compared with COX/SDH regions. mtDNA-de-
letion mutations were present at a very low abundance
(!20%) in the ETS-normal segments immediately adjacent
to the abnormal regions, whereas, in the ETS-normal
regions distant from the ETS abnormality, only wild-type
genomes were observed.
Discussion
For mtDNA-deletion mutations and their associated ETS
abnormalities to be physiologically relevant, they must be
present in a signiﬁcant number of cells and accumulate
to high levels intracellularly. In this study of human mus-
cle, ETS-abnormal (COX/SDH) ﬁbers were identiﬁed in
all biopsy samples, three of which were extensively ana-
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Figure 2. Schematic representation of the human mtDNA-deletion mutations obtained from 48 COX/SDH ﬁbers. mtDNA-deletion
mutations were detected in all 48 ETS-abnormal ﬁbers, and breakpoints were determined by DNA sequence analysis. Arcs represent the
deleted regions of the genome. The location of the light-strand (OL) and the heavy-strand (OH) origins of replication are indicated. Cyt
p cytochrome.
Figure 3. Log10 of mtDNA wild-type and partially deleted ge-
nomes along the length of ﬁbers 19, 36, 37, and 23. The legend
is available in its entirety in the online edition of The American
Journal of Human Genetics.
lyzed (200 consecutive 10-mm sections) and provided an
estimate of the abundance of ﬁbers exhibiting ETS abnor-
malities. Extrapolating the percentage of ETS abnormali-
ties found in the analyzed 2,000-mm region to the entire
length of VL ﬁbers (∼6.5 cm),33 we estimate that ∼6% of
muscle ﬁbers from the 49-year-old individual, ∼22% of
muscle ﬁbers from the 67-year-old individual, and ∼31%
from the 92-year-old individual contain ETS abnormalities
somewhere along their length. These calculations suggest
that a large number of ﬁbers in the muscles of older sub-
jects contain ETS abnormalities and, thus, initiate a pro-
cess that will eventually lead to ﬁber breakage and, ulti-
mately, ﬁber loss. Similar calculations in aged rats and
rhesus monkeys indicate that 5%–15% and 28%–60% of
the ﬁbers, respectively, contain an ETS-abnormal pheno-
type somewhere along the length.4,12
The mosaic distribution and segmental nature of ETS
abnormalities necessitated the analysis of mtDNA muta-
tions from single-ﬁber sections. LCM was combined with
PCR and direct mtDNA sequencing to deﬁne the mtDNA
genotype of ﬁbers exhibiting a COX/SDH abnormal
phenotype. mtDNA-deletion mutations, with removal of
1%–72% of the genome, were observed in every analyzed
COX/SDH region. These results contrast with those of
Fayet et al.,34 which showed mtDNA mutations in 10% of
the COX ﬁbers. However, Fayet et al.34 examined COX
ﬁbers, whereas our study focused on ﬁbers with a dual
ETS-abnormal phenotype, COX/SDH.
Although mtDNA-deletion mutations accrue and accu-
mulate with age in many species, our studies have iden-
tiﬁed a number of subtle differences in the nature of the
deletion breakpoints. Direct repeat sequences are present
at many of the mtDNA-deletion breakpoints in human
and rhesus monkey COX/SDH skeletal-muscle ﬁbers but
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Figure 4. mtDNA deletion–mutation abundance along the length of COX/SDH ﬁbers. LCM was used to isolate 10-mm thick tissue
sections at numerous sites along the length of single muscle ﬁbers. Quantitative PCR deﬁned the abundance of full-length and deleted
mtDNA. A, B, and C, Percentage of deleted mtDNA7664 in the abnormal region of ﬁbers 19, 36, and 37, respectively. D, Percentage of
deleted mtDNA4989 in the abnormal region of ﬁber 23. a, Photomicrographs of tissue cross-sections sequentially double stained for COX
and SDH activity. The individual ﬁber (arrow) displays an ETS-abnormal phenotype. b, Digital reconstruction of CSA silhouettes. The
COX/SDH region is shown in dark blue, the COXlow/SDHhigh region in light blue, and the COXnormal/SDHnormal in orange.
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Figure 5. mtDNA4977 deletion mutation in tissue homogenate
from aged human skeletal muscle. The legend is available in its
entirety in the online edition of The American Journal of Human
Genetics.
Figure 6. Accumulation, with age, of mtDNA4977 and mtDNA7664
deletion mutation in tissue homogenate. The legend is available
in its entirety in the online edition of The American Journal of
Human Genetics.
are rarely observed at rat mtDNA-deletion breakpoints.21,31
Interestingly, in humans, most of the mtDNA-deletion
mutations with direct repeat sequences were identiﬁed in
ﬁbers from older individuals (aged 60–90 years). The ma-
jority of the deletion breakpoints in human VL muscle
were located in the major arc, with both origins of rep-
lication preserved and with only two deletion mutations
missing the OL. A similar loss of theOL regionwas observed
in 28% of the mtDNA-deletion mutations present in ETS-
abnormal ﬁbers from aged rhesus monkey skeletal mus-
cle.12,31 Deletion mutations are, however, exclusively con-
ﬁned within the major arc in single ETS-abnormal ﬁbers
from aged rats.4,21 Patterns ofmtDNAdeletions inhumans,
rats, and rhesus monkeys suggest species-speciﬁc differ-
ences that could be due to different life spans or different
processes associated with deletion formation.
mtDNA-deletionmutations located in thehypervariable
site 1 (HVS1 [nucleotide position 16024–16383, GenBank
accession 1944628) of the genome were observed in four
ﬁbers. This region of the genome is thought to be a mu-
tational hotspot region for both germline and somaticmu-
tations of mtDNA.35 Deletions of this site were described
elsewhere in patients with CPEO (MIM 530000) as well as
in healthy older individuals.34,36
Considerable attention has been focused on the
mtDNA4977 deletion mutation that causes many sporadic
mitochondrial myopathies. Initial mtDNA-aging studies
focused solely on this mutation and found that it accu-
mulates with age in a variety of tissues.16,17 We did not
identifymtDNA4977 in anyof the analyzed individualCOX/
SDH ﬁbers. The deletion was, however, detected in every
sample (from subjects aged 49–93 years) when tissue ho-
mogenates (tens of thousands of ﬁbers) were analyzed (see
ﬁg. 5). Quantitative PCR analysis of tissue homogenates
demonstrated that the abundance of mtDNA4977 increased
with age (see ﬁg. 6a). The mtDNA7664 deletion mutation,
which is also linked to sporadicmyopathies, was identiﬁed
in ﬁve COX/SDH ﬁbers. Interestingly, in the same tis-
sue homogenates, the abundance of the mtDNA7664 dele-
tion mutation—which, in COX/SDH ﬁbers, was found
to accumulate to high levels—was ∼10-fold lower than
mtDNA4977 (see ﬁg. 6b). Our inability to identify ETS-ab-
normal ﬁbers containing the mtDNA4977 mutation may
reﬂect the number of other deletion mutations that can
also accumulate and trigger the COX/SDH phenotype.
In support of this argument, other studies have reported
the presence of mtDNA4977 in a very small proportion of
COX ﬁbers.34,37 Another possibility is that mtDNA4977
rarely accumulates to sufﬁciently high levels to result in
an observable phenotype. Alternatively, the generation of
deletion mutations could be tissue speciﬁc, since tissue
homogenates contain—in addition to muscle ﬁbers—ner-
vous and connective tissue, blood vessels, and adipose cells.
Quantitative analysis of the abundance of mtDNA-de-
letion mutations along the length of individual COX/
SDH skeletal-muscle ﬁbers facilitates a better under-
standing of the relationship between mtDNA-deletion
mutations and their concomitant phenotypes: ETS ab-
normalities and intraﬁber atrophy. Studies of mitochon-
drial myopathies show that ∼80%–100% of the mtDNA
must be of the mutant type for there to be an observable
ETS phenotype.23,38,39 We found mtDNA-deletion muta-
tions to clonally accumulate to high levels within COX/
SDH regions (180% of total mtDNA). Declining levels
of the deletion-containing genomes in the transition
regions and in ETS-normal regions immediately adjacent
to the transition regions suggest that the accumulation of
mtDNA-deletion mutations precedes the ETS-abnormal
phenotype. These observations strongly support the hy-
pothesis thatmtDNA-deletionmutations play a causal role
inmitochondrial and cellular dysfunction of skeletal-mus-
cle ﬁbers with age, a process that ultimately leads to ﬁber
loss.
The data presented in this work further delineate the
involvement of mitochondria in skeletal-muscle aging and
suggest a speciﬁc order of molecular and cellular events
that occur in response to the accumulation of mtDNA
mutations. Sporadic mtDNA-replication errors or mtDNA-
replication errors resulting from oxidative damage may
cause large-scale deletions that result in the loss or trun-
cation of mtDNA genes that encode subunits of the re-
spiratory chain, ATP synthase, rRNA, and tRNA genes.40–44
Within a ﬁber, a given genome with deletion replicates
to high levels, impairing the enzymatic activity of the
ETS complex and altering the mitochondrial metabolism.
Whereas wild-type mtDNA is present in both ETS-normal
and -abnormal regions at a relatively constant level,
mtDNA-deletionmutations accumulate to very high levels
in COX/SDH regions ofmuscle ﬁbers. Our data indicate
that there is a threshold of mtDNA deletion–mutation
abundance necessary for the expression of an ETS-abnor-
mal phenotype. An ETS-normal phenotype is observed
when only full-length mtDNA or low levels of mtDNA-
deletion mutations are present (!20%). When 20%–80%
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of the genomes have deletions, the ﬁber exhibits an in-
termediate ETS-abnormal phenotype, the COX/SDHnormal
phenotype. As the ratio of deletion-containing genomes
increases (to 180%), the ﬁbers manifest the COX/SDH
phenotype. With time, the ETS-abnormal region extends
throughout the length of the ﬁber and results in ﬁber
atrophy, ﬁber breakage, and thus ﬁber loss.
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